A New Chapter for Walgreens as It Exits Public Markets

After nearly a century as a publicly traded company, Walgreens Boots Alliance has concluded its stock market journey. The landmark acquisition by private equity firm Sycamore Partners, valued at approximately $10 billion, was finalized on August 28, delisting the iconic pharmacy chain from the Nasdaq.

Shareholders received a cash payment of $11.45 per share, representing a significant 29% premium over the stock price from December 2024. An additional incentive of up to $3 per share is contingent on the successful divestiture of healthcare divisions, including VillageMD and Summit Health.

The decision to go private follows a period of substantial financial difficulty for the retailer. The company reported a staggering $8.6 billion loss for 2024, nearly triple the deficit from the previous year. This performance precipitated a dramatic... Read more...